首页> 外文OA文献 >CFU-GM Capacity, Engraftment, and Long-Term Graft Function: A Comparison of Three Methods of Peripheral Blood Hematopoietic Stem Cell Mobilization (G-CSF, G-CSF + Plerixafor, or Cyclophosphamide + G/GM-CSF) in Patients Receiving Similar CD34+ Cell Doses

【2h】

CFU-GM Capacity, Engraftment, and Long-Term Graft Function: A Comparison of Three Methods of Peripheral Blood Hematopoietic Stem Cell Mobilization (G-CSF, G-CSF + Plerixafor, or Cyclophosphamide + G/GM-CSF) in Patients Receiving Similar CD34+ Cell Doses

机译：CFU-GM的容量，植入和长期移植功能：接受相似治疗的患者外周血造血干细胞动员的三种方法（G-CSF，G-CSF + Plerixafor或环磷酰胺+ G / GM-CSF）的比较CD34 +细胞剂量

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alexander E.T.; Towery J.A.; Squires J.E.; Kramer C.; Stuart R.K.; Costa L.J.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 单一剂量G-CSF用于异基因外周血造血干细胞动员和移植后造血恢复的临床研究 [J] . 田红, 周淑芸, 广东省干细胞移植协作组癌症（英文版） . 2003,第012期
2. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor (G-CSF), G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage (GM)-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function. [J] . Alexander ET, Towery JA, Miller AN, Transfusion: The Journal of the American Association of Blood Banks . 2011,第9期

机译：超出CD34 +细胞剂量：外周血造血干细胞动员方法（粒细胞集落刺激因子（G-CSF），G-CSF加plerixafor或环磷酰胺G-CSF /粒细胞巨噬细胞（GM）-CSF）的影响集落形成单位的数量-GM，植入和第100天以上的造血移植功能。
3. Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF [J] . ChaudharyL., AwanF., CumpstonA., Journal of clinical apheresis. . 2013,第5期

机译：在多发性骨髓瘤患者中，外周血干细胞动员在新的治疗时代中使用培来沙福和G-CSF进行治疗，与低剂量环磷酰胺和G-CSF进行动员相比具有更高的疗效，但成本却更高
4. Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF vs. Cyclophosphamide and G-CSF in Patients with Multiple Myeloma: A Reassessment in View of Increased Costs of Cyclophosphamide [J] . Chen Christopher Chun Man, Campen Christopher, McBride Ali, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：多发性骨髓瘤患者使用Plerixafor和G-CSF与Cyclophosphamide和G-CSF进行自体外周血干细胞动员的成本和结果分析：鉴于环磷酰胺成本增加，需要重新评估
5. Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function [C] . Hal E. Broxmeyer International Conference and Workshop on Hematopoietic Stem Cells . 2012

机译：通过洞察茎/祖细胞功能的洞察力增强脐带血细胞的植入
6. Leptin Receptor, a Surface Marker for a Subset of Highly Engrafting Long-Term Functional Hematopoietic Stem Cells [D] . Trinh, Thao Le Phuong. 2021

机译：Leptin受体，一种高度植入长期功能造血干细胞的表面标志物的表面标志物
7. Safety and Efficacy of Upfront Plerixafor + G-CSF vs. Placebo + G-CSF for Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients ≥60 and 60 Years of Age with Non-Hodgkin’s Lymphoma or Multiple Myeloma [O] . Ivana N. Micallef, Patrick J. Stiff, Edward A. Stadtmauer, -1

机译：60岁以上和60岁以下非霍奇金淋巴瘤或多发性骨髓瘤患者中前者Plerixafor + G-CSF与安慰剂+ G-CSF调动CD34 +造血祖细胞的安全性和有效性
8. Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF vs. Cyclophosphamide and G-CSF in Patients with Multiple Myeloma: A Reassessment in View of Increased Costs of Cyclophosphamide [O] . Christopher Chun Man Chen, Christopher Campen, Ali McBride, 2016

机译：具有多骨瘤患者的基磷脂和G-CSF与G-CSF与G-CSF与环磷酰胺和G-CSF的成本和结果分析：鉴于环磷酰胺成本的重新评估

CFU-GM Capacity, Engraftment, and Long-Term Graft Function: A Comparison of Three Methods of Peripheral Blood Hematopoietic Stem Cell Mobilization (G-CSF, G-CSF + Plerixafor, or Cyclophosphamide + G/GM-CSF) in Patients Receiving Similar CD34+ Cell Doses

著录项

引文网络

相似文献

相关主题

期刊订阅